Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Tandem Diabetes (TNDM) Avails Tandem Source in the United States
12:47pm, Thursday, 14'th Dec 2023
Tandem Diabetes (TNDM) announces the full U.S. launch of Tandem Source, a new diabetes management platform for customers and healthcare providers.
Tandem Diabetes (TNDM) Launches Dexcom G7 Integrated t:slim X2
08:17am, Thursday, 07'th Dec 2023
Tandem Diabetes' (TNDM) t:slim X2 is the first AID system in the world to feature Dexcom's most advanced CGM technology.
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
08:16am, Tuesday, 07'th Nov 2023
Investors remain optimistic about Tandem Diabetes (TNDM), backed by upcoming innovative launches, including Mobi and the new integrated CGM offering.
Tandem Diabetes (TNDM) Posts Wider Q3 Loss, Trims '23 Sales View
09:01am, Thursday, 02'nd Nov 2023
Tandem Diabetes (TNDM) reports a higher-than-anticipated loss in the third quarter of 2023.
Tandem Diabetes Care, Inc. (TNDM) Q3 2023 Earnings Call Transcript
10:22pm, Wednesday, 01'st Nov 2023
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Susan Morrison - EVP & Chief Administrative Officer John Sheridan - Presiden
Compared to Estimates, Tandem Diabetes Care, Inc. (TNDM) Q3 Earnings: A Look at Key Metrics
07:32pm, Wednesday, 01'st Nov 2023
Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics co
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
07:50am, Thursday, 26'th Oct 2023
AbbVie has good reasons for investors to take a close look at the stock, even though its best-selling drug recently lost patent exclusivity. Tandem Diabetes Care has plenty of room to increase sales,
Tandem Diabetes Care, Inc. (TNDM) Soars 6.0%: Is Further Upside Left in the Stock?
09:47am, Monday, 16'th Oct 2023
Tandem Diabetes Care, Inc. (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in
Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023
04:05pm, Tuesday, 10'th Oct 2023
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2023 results aft
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
09:46am, Monday, 09'th Oct 2023
Investors remain optimistic about Tandem Diabetes (TNDM), backed by strategic developments and innovative new launches.
Diabetes-related stocks take hit over weight loss drug craze
01:00pm, Saturday, 07'th Oct 2023
This segment originally aired on October 5, 2023 Weight loss drugs, like Novo Nordisk's (NVO) Ozempic, have become popular across healthcare providers in regard to diabetes treatment. Although use is
Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn
05:53am, Wednesday, 04'th Oct 2023
In recent months, diabetes stocks have retreated sharply, partly due to the increased popularity of the weight-loss drug Semaglutide. Some have contended that Semaglutide will greatly reduce the numbe
Weight-Loss-Drug Stock Sting May Be Easing for Device Makers
01:59pm, Monday, 02'nd Oct 2023
Wall Street says insulin pump maker Insulet and Tandem Diabetes, as well as glucose-monitor maker DexCom, look ready to rise after pressure from Novo Nordisk's Wegovy and Eli Lilly.
2 Stocks Under $25 to Buy and Hold for 10 Years
10:07am, Friday, 29'th Sep 2023
Shares of Tandem Diabetes Care and Teladoc Health haven't performed well recently. Tandem still has a long way to go in the insulin-pump space and demand should grow.
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
10:31am, Friday, 25'th Aug 2023
Investors continue to be optimistic about Tandem Diabetes (TNDM) due to the t:slim X2 insulin pump and new product innovations.
